CA2239183A1 - Segments de liaison hydrazone ramifies - Google Patents

Segments de liaison hydrazone ramifies

Info

Publication number: CA2239183A1
Authority: CA; Canada
Prior art keywords: hydrazone linkers; branched; branched hydrazone; branching; linkers
Prior art date: 1995-12-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA002239183A

Other languages

English (en)

Other versions

CA2239183C (fr

Inventor

Dalton King

Raymond A. Firestone

Pamela Trail

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bristol Myers Squibb Co

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-22

Filing date

1996-12-17

Publication date

1997-07-03

1996-12-17 Application filed by Individual filed Critical Individual

1996-12-17 Priority claimed from PCT/US1996/020513 external-priority patent/WO1997023243A1/fr

1997-07-03 Publication of CA2239183A1 publication Critical patent/CA2239183A1/fr

2006-08-29 Application granted granted Critical

2006-08-29 Publication of CA2239183C publication Critical patent/CA2239183C/fr

2016-12-17 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

229940079593 drug Drugs 0.000 abstract 3
239000003814 drug Substances 0.000 abstract 3
AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 abstract 2
229960004679 doxorubicin Drugs 0.000 abstract 1
239000003446 ligand Substances 0.000 abstract 1
230000008685 targeting Effects 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

CA002239183A 1995-12-22 1996-12-17 Segments de liaison hydrazone ramifies Expired - Lifetime CA2239183C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US910095P	1995-12-22	1995-12-22
US60/009,100		1995-12-22
PCT/US1996/020513 WO1997023243A1 (fr)	1995-12-22	1996-12-17	Segments de liaison hydrazone ramifies

Publications (2)

Publication Number	Publication Date
CA2239183A1 true CA2239183A1 (fr)	1997-07-03
CA2239183C CA2239183C (fr)	2006-08-29

Family

ID=29405601

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002239183A Expired - Lifetime CA2239183C (fr)	1995-12-22	1996-12-17	Segments de liaison hydrazone ramifies

Country Status (1)

Country	Link
CA (1)	CA2239183C (fr)

1996
- 1996-12-17 CA CA002239183A patent/CA2239183C/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2239183C (fr)	2006-08-29

Similar Documents

Publication	Publication Date	Title
MX9804386A (es)	1998-09-30	Enlaces de hidrazona ramificados.
EP0336364A3 (fr)	1990-06-20	Substrats cellulaires modifiés utilisés comme linkers pour une rétention supérieure d'agents diagnostiques et thérapeutiques dans les cellules
EP0354729A3 (fr)	1991-04-17	Conjugués de médicaments cytotoxiques
AU5263496A (en)	1996-10-23	Targeted catheter drug administration
AU1534699A (en)	1999-06-28	Osmotic dosage form comprising first and second coats
EP0841932A4 (fr)	1998-12-30	Amelioration de l'administration de medicaments par saponines modifiees
CA2012480A1 (fr)	1990-11-16	Isolement et elucidation de la structure d'un depsipeptide lineaire cytostatique, le dolastatin 15
AU6385396A (en)	1996-12-24	Drug mitochondrial targeting agents
IS2537B (is)	2009-08-15	Lyfjablanda til inngjafar um húð
AU6368596A (en)	1997-02-18	Pharmaceutical composition of l-dopa ethyl ester
IL135148A0 (en)	2001-05-20	A polysaccharide conjugate and pharmaceutical compositions containing the same
AU6046396A (en)	1997-01-09	Tricot-like pouch for the delivery of topical drugs and cosm etics
CA2203694A1 (fr)	1996-05-23	Peptides inhibiteurs du cancer
FI904207A7 (fi)	1990-08-24	Rasvahappo-lääkeainekonjugaatti lääkkeen kuljettamiseksi veri-aivo-est een läpi
NO975931D0 (no)	1997-12-17	Blanding for administrering av medikament
CA2264960A1 (fr)	1998-03-05	Formulation externe contenant loxoprofen
CA2210751A1 (fr)	1997-05-29	Anticorps monoclonaux anti-cd6 et ses utilisations
CA2150925A1 (fr)	1994-06-23	Synthese amelioree de conjugues polymeriques bioactifs
WO1999007401A3 (fr)	1999-04-29	Utilisation de preparations d'erythropoietine et de fer pour la production de preparations pharmaceutiques mixtes destinees au traitement de maladies rhumatismales
DE69637961D1 (de)	2009-08-13	Verabreichung von biologisch aktiven polypeptiden
FR2741075B1 (fr)	1998-01-30	Conjugues peptidiques, leur utilisation a titre de medicament et compositions les contenant
WO1996025956A3 (fr)	1996-12-27	Conjugue pour le dosage individuel de medicaments
AU6633596A (en)	1997-02-26	Improved therapeutic agents
IL116912A0 (en)	1996-07-23	Novel pharmaceutical combination for topical administration
ATE296115T1 (de)	2005-06-15	Ortsspezifische arzneimittel verabreichung

Legal Events

Date	Code	Title	Description
2001-12-12	EEER	Examination request
2017-02-20	MKEX	Expiry	Effective date: 20161219